11 Einträge gefunden

1. Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer

   1. Hennigs, Jan K
   2. Minner, Sarah
   3. Tennstedt, Pierre
   4. Löser, Rolf
   5. Huland, Hartwig
   6. Klose, Hans
   7. Graefen, Markus

   2020 - Forschungsinformationssystem des UKE
2. Random forest-based modelling to detect biomarkers for prostate cancer progression

   1. Toth, Reka
   2. Schiffmann, Heiko
   3. Hube-Magg, Claudia
   4. Büscheck, Franziska
   5. Höflmayer, Doris
   6. Weidemann, Sören
   7. Lebok, Patrick

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
3. PSMA expression is highly homogenous in primary prostate cancer

   1. Tsourlakis, Maria C
   2. Klein, Franka
   3. Kluth, Martina
   4. Quaas, Alexander
   5. Graefen, Markus
   6. Haese, Alexander
   7. Simon, Ronald

   2015 - Forschungsinformationssystem des UKE
4. Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility

   1. Schiffmann, Jonas
   2. Wenzel, Philipp
   3. Salomon, Georg
   4. Budäus, Lars
   5. Schlomm, Thorsten
   6. Minner, Sarah
   7. Wittmer, Corinna

   2015 - Forschungsinformationssystem des UKE
5. Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR

   1. Tennstedt, Pierre
   2. Bölch, Charlotte
   3. Strobel, Gundula
   4. Minner, Sarah
   5. Burkhardt, Lia
   6. Grob, Tobias
   7. Masser, Sawinee

   2014 - Forschungsinformationssystem des UKE
6. Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse

   1. Hennigs, Jan K
   2. Müller, Juliane
   3. Adam, Matti
   4. Spin, Joshua M
   5. Riedel, Emilia
   6. Graefen, Markus
   7. Bokemeyer, Carsten

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
7. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

   1. Flammiger, Anna
   2. Weisbach, Lars
   3. Huland, Hartwig
   4. Tennstedt, Pierre
   5. Simon, Ronald
   6. Minner, Sarah
   7. Bokemeyer, Carsten

   2013 - Forschungsinformationssystem des UKE
8. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

   1. Stumm, Laura
   2. Burkhardt, Lia
   3. Steurer, Stefan
   4. Simon, Ronald
   5. Adam, Meike
   6. Becker, Andreas
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
9. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

   1. Tsourlakis, Maria Christina
   2. Schoop, Michael
   3. Plaß, Christoph
   4. Huland, Hartwig
   5. Graefen, Markus
   6. Steuber, Thomas
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
10. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

    1. Grupp, Katharina
    2. Kohl, Sebastian
    3. Sirma, Hüseyin
    4. Simon, Ronald
    5. Steurer, Stefan
    6. Becker, Andreas
    7. Adam, Meike

    2013 - Forschungsinformationssystem des UKE
11. The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

    1. Tennstedt, Pierre
    2. Köster, Patricia
    3. Brüchmann, Andreas
    4. Mirlacher, Martina
    5. Haese, Alexander
    6. Steuber, Thomas
    7. Sauter, Guido

    2012 - Forschungsinformationssystem des UKE